Skip to main content

BECTON DICKINSON AND COMPANY

corporate_fare Company Profile

BECTON DICKINSON AND COMPANY

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Exchange: NYSESector: Industrial Applications And Services

BECTON DICKINSON AND COMPANY (NYSE:BDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BDX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • BD Finalizes Underwriting for €600M Euro Notes, Refinancing 2026 Debt
  • Becton Dickinson Subsidiary Files for €600M Euro Notes Offering
  • Becton Dickinson Euro Finance Prices €600M Notes Due 2033
  • BD and Bactiguard Strengthen Global Partnership for Infection-Reducing Catheters
  • Becton Dickinson Posts Q3 Net Loss of $311M, EPS $(1.11) Despite Revenue Growth

show_chartPrice Chart

Loading chart...

feed BDX - Latest Insights

BDX
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
BDX
May 11, 2026, 6:21 PM EDT
Source: Reuters
Importance Score:
7
BDX
May 11, 2026, 4:26 PM EDT
Filing Type: FWP
Importance Score:
7
BDX
May 11, 2026, 8:40 AM EDT
Source: MFN by Modular Finance
Importance Score:
7
BDX
May 07, 2026, 5:25 PM EDT
Source: Wiseek News
Importance Score:
8
BDX
May 07, 2026, 7:56 AM EDT
Source: Reuters
Importance Score:
9
BDX
May 07, 2026, 6:33 AM EDT
Filing Type: 8-K/A
Importance Score:
7
BDX
May 07, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BDX
Apr 10, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
9
BDX
Apr 09, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
BDX
Apr 02, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
BDX
Feb 25, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
8
BDX
Feb 10, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
BDX
Feb 09, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
BDX
Feb 09, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
9
BDX
Feb 09, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
BDX
Feb 05, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
7
BDX
Feb 05, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7